Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04433182
Title Copanlisib With Rituximab-Bendamustine in Patients With Relapsed-Refractory Diffuse Large B-cell Lymphoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fondazione Italiana Linfomi ONLUS
Indications

diffuse large B-cell lymphoma

Therapies

Bendamustine + Copanlisib + Rituximab

Copanlisib

Age Groups: adult | senior
Covered Countries ITA


No variant requirements are available.